与抗血管内皮生长因子注射相关的系统性动脉和静脉血栓事件:一个元分析
Aaditeya Jhaveri1, Michael Balas1, Faran Khalid2
1From the Temerty Faculty of Medicine (A.J., M.B., A.M.), University of Toronto, Toronto, Ontario, Canada.
American journal of ophthalmology
|January 20, 2024
概括
与假注射相比,静脉内抗VEGF注射显示出与假注射相比,系统性血栓事件的风险类似. 这次元分析发现,在各种抗VEGF药物之间,动脉或静脉血栓事件没有显著差异.
科学领域:
- 眼科医生 眼科 眼科
- 血管生物学 血管生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 内抗血管内皮生长因子 (anti-VEGF) 药物广泛用于视网膜疾病.
- 人们对与这些治疗相关的潜在系统性血栓形成风险存在担忧.
研究的目的:
- 为了比较肠内抗VEGF药物和假注射之间的系统性动脉静脉血栓事件的风险.
主要方法:
- 进行了一项随机效应元分析.
- 从2005年1月到2023年8月,对OVID MEDLINE,Embase和Cochrane图书馆进行了系统的搜索.
- 包括随机对照试验 (RCT),报告标准剂量内抗VEGF药物的系统性动脉静脉事件.
主要成果:
- 分析了20个涉及12833只眼睛的RCT.
- 在贝瓦西祖马布和拉尼比祖马布之间没有发现血栓事件的显著差异.
- 动脉和静脉血栓事件的风险在各种抗VEGF药物 (aflibercept,brolucizumab,faricimab) 中相似,并且与拉尼比祖马布的假注射相比.
结论:
- 系统性动脉静脉血栓性不良事件的风险在不同的抗VEGF药物中是相似的.
- 与假注射相比,拉尼比祖马布注射似乎不会增加动脉血栓事件的风险.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins
701
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
701


